• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个患有原肌球蛋白介导的肥厚型心肌病且儿童期猝死的家族的临床谱。

Clinical spectrum in a family with tropomyosin-mediated hypertrophic cardiomyopathy and sudden death in childhood.

作者信息

Makhoul Majd, Ackerman Michael J, Atkins Dianne L, Law Ian H

机构信息

Department of Pediatric Cardiology, University of Iowa Children's Hospital, Iowa City, IA, USA.

出版信息

Pediatr Cardiol. 2011 Feb;32(2):215-20. doi: 10.1007/s00246-010-9843-1. Epub 2010 Nov 19.

DOI:10.1007/s00246-010-9843-1
PMID:21085943
Abstract

This report demonstrates variable clinical courses in several members of a family with tropomyosin-mediated hypertrophic cardiomyopathy (HCM) (L185R mutation). The index case was an 8-year-old girl who died from sudden cardiac death and was diagnosed with HCM on autopsy. Her father had minimal hypertrophy but had an implantable cardioverter defibrillator placed prophylactically with no appropriate shocks. Two brothers progressed from normal phenotype to HCM on follow-up, the younger with significant hypertrophy and the older with mild hypertrophy. They both had malignant arrhythmia courses with VF, which was terminated by ICD shock. In conclusion, family members with same genotype can have significantly variable phenotypes.

摘要

本报告展示了一个患有原肌球蛋白介导的肥厚型心肌病(HCM)(L185R突变)的家族中几名成员的不同临床病程。索引病例是一名8岁女孩,死于心源性猝死,尸检时被诊断为HCM。她的父亲仅有轻微肥厚,但预防性植入了植入式心律转复除颤器,未发生过恰当电击。两名兄弟在随访中从正常表型发展为HCM,弟弟有显著肥厚,哥哥有轻度肥厚。他们都有室颤的恶性心律失常病程,均通过植入式心律转复除颤器电击终止。总之,具有相同基因型的家族成员可具有显著不同的表型。

相似文献

1
Clinical spectrum in a family with tropomyosin-mediated hypertrophic cardiomyopathy and sudden death in childhood.一个患有原肌球蛋白介导的肥厚型心肌病且儿童期猝死的家族的临床谱。
Pediatr Cardiol. 2011 Feb;32(2):215-20. doi: 10.1007/s00246-010-9843-1. Epub 2010 Nov 19.
2
Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.肥厚型心肌病患者皮下植入式心律转复除颤器中的适当和不适当电击:一项国际多中心研究。
Heart Rhythm. 2020 Jul;17(7):1107-1114. doi: 10.1016/j.hrthm.2020.02.008. Epub 2020 Feb 18.
3
Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.安大略省年轻人肥厚型心肌病相关心源性猝死。
Circulation. 2019 Nov 19;140(21):1706-1716. doi: 10.1161/CIRCULATIONAHA.119.040271. Epub 2019 Oct 21.
4
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.肥厚型心肌病患者皮下植入式心律转复除颤器:初步经验
J Am Heart Assoc. 2016 Feb 12;5(2):e002488. doi: 10.1161/JAHA.115.002488.
5
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.植入式心脏复律除颤器与肥厚型心肌病心脏性猝死的预防
JAMA. 2007 Jul 25;298(4):405-12. doi: 10.1001/jama.298.4.405.
6
A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood.一个患有肥厚型心肌病且在儿童期发生心源性猝死的家族中的一种新型TPM1突变。
Am J Cardiol. 2002 Nov 15;90(10):1123-7. doi: 10.1016/s0002-9149(02)02780-7.
7
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.肥厚型心肌病和植入式心脏复律除颤器高危患者的临床过程和生活质量。
Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005820. doi: 10.1161/CIRCEP.117.005820.
8
Clinical characteristics of hypertrophic cardiomyopathy in children: An 8-year single center experience.儿童肥厚型心肌病的临床特征:8 年单中心经验。
Pediatr Int. 2021 Jan;63(1):37-45. doi: 10.1111/ped.14393. Epub 2020 Dec 5.
9
Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study.肥厚型心肌病伴植入式除颤器患儿和青少年致死性心律失常事件的危险因素:一项国际多中心研究。
Heart Rhythm. 2019 Oct;16(10):1462-1467. doi: 10.1016/j.hrthm.2019.04.040. Epub 2019 Apr 23.
10
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.植入式心律转复除颤器预防肥厚型心肌病儿童和青少年心源性猝死。
J Am Coll Cardiol. 2013 Apr 9;61(14):1527-35. doi: 10.1016/j.jacc.2013.01.037.

引用本文的文献

1
Mechanistic heterogeneity in contractile properties of α-tropomyosin (TPM1) mutants associated with inherited cardiomyopathies.与遗传性心肌病相关的α-原肌球蛋白(TPM1)突变体收缩特性的机制异质性
J Biol Chem. 2015 Mar 13;290(11):7003-15. doi: 10.1074/jbc.M114.596676. Epub 2014 Dec 29.
2
Structural and protein interaction effects of hypertrophic and dilated cardiomyopathic mutations in alpha-tropomyosin.α-原肌球蛋白中肥厚型和扩张型心肌病突变的结构及蛋白质相互作用效应
Front Physiol. 2014 Dec 2;5:460. doi: 10.3389/fphys.2014.00460. eCollection 2014.
3
Genetic testing in the contemporary diagnosis of cardiomyopathy.

本文引用的文献

1
Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.肥厚型心肌病猝死风险分层与预防的当代见解和策略
Circulation. 2010 Jan 26;121(3):445-56. doi: 10.1161/CIRCULATIONAHA.109.878579.
2
Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.儿童孤立性肥厚型心肌病的危险因素及死亡方式
J Am Coll Cardiol. 2009 Jul 14;54(3):250-4. doi: 10.1016/j.jacc.2009.03.051.
3
Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy.
基因检测在心肌病当代诊断中的应用
Curr Heart Fail Rep. 2013 Mar;10(1):63-72. doi: 10.1007/s11897-012-0124-6.
MYH7相关肥厚型心肌病在心室肥厚发生前出现心室颤动。
Heart Rhythm. 2009 Sep;6(9):1366-9. doi: 10.1016/j.hrthm.2009.04.029. Epub 2009 May 4.
4
Significance of left atrial volume in patients < 20 years of age with hypertrophic cardiomyopathy.
Am J Cardiol. 2008 Nov 15;102(10):1390-3. doi: 10.1016/j.amjcard.2008.07.027. Epub 2008 Sep 11.
5
Hypertrophic cardiomyopathy.肥厚型心肌病
Anesthesiology. 2006 Jan;104(1):183-92. doi: 10.1097/00000542-200601000-00025.
6
Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.389例非亲缘关系肥厚型心肌病患者中肾素-血管紧张素-醛固酮系统相关促左心室肥厚多态性的基因特异性修饰作用
Eur Heart J. 2005 Nov;26(22):2457-62. doi: 10.1093/eurheartj/ehi438. Epub 2005 Aug 8.
7
American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.美国心脏病学会/欧洲心脏病学会关于肥厚型心肌病的临床专家共识文件。美国心脏病学会基金会临床专家共识文件特别工作组及欧洲心脏病学会实践指南委员会的报告。
J Am Coll Cardiol. 2003 Nov 5;42(9):1687-713. doi: 10.1016/s0735-1097(03)00941-0.
8
A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood.一个患有肥厚型心肌病且在儿童期发生心源性猝死的家族中的一种新型TPM1突变。
Am J Cardiol. 2002 Nov 15;90(10):1123-7. doi: 10.1016/s0002-9149(02)02780-7.
9
Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.肥厚型心肌病中β-肌球蛋白重链和肌钙蛋白T基因恶性突变的患病率及年龄依赖性:一项综合门诊视角的研究
J Am Coll Cardiol. 2002 Jun 19;39(12):2042-8. doi: 10.1016/s0735-1097(02)01900-9.
10
Hypertrophic cardiomyopathy: a systematic review.肥厚型心肌病:一项系统综述。
JAMA. 2002 Mar 13;287(10):1308-20. doi: 10.1001/jama.287.10.1308.